Prognostic Markers of Patients With STEMI

Prognostic Markers of Patients With ST-segment Elevation Myocardial Infarction

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03527940

Enrollment

932

Registered

2018-05-17

Start date

2015-09-17

Completion date

2020-01-01

Last updated

2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI - ST Elevation Myocardial Infarction

Brief summary

To analyze the relationship between the clinical data and the outcomes of STEMI patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Patients diagnosed with ST-segment elevation myocardial infarction(STEMI).

Exclusion criteria

* Patients with concurrent infection or any documented inflammatory illness, such as arthritis or connective tissue diseases,or any other malignancy. * Pregnant women. * Severe hepatic dysfunction. * Uncontrolled hypertension.

Design outcomes

Primary

Measure	Time frame
All cause mortality	3 years

Countries

China

Outcome results